Quality Use of Medicines

Quality use of medicines (QUM) is about choosing suitable medicines if a medicine is considered necessary, using medicines safely and effectively to get the best possible results, and selecting management options wisely.

GP partners Australia works in partnership with the Drug and Therapeutics Information Service (DATIS) based at the Repatriation Hospital to provide General Practitioners and Practice staff with quality evidence based educational information about medicines and therapeutics.

PodCasts

GP partners Australia has established a regular quarterly segment with radio 5RPH Adelaide. This commenced in late 2010. 5RPH is a not-for-profit, disability service provider delivering a reading and information service to the print handicapped. Promoting the Quality Use of Medicines message was the initial impetus for these segments which utilise a variety of health professionals.

Listen to past 5RPH Interviews as the following podcasts:

Home Medicine Review

A Home Medicines Review (HMR), also known as Domiciliary Medication Management Review (DMMR), is intended to maximise an individual patient's benefit from their medication regimen, and prevent medication-related problems.

A HMR allows a thorough check of all the medicines a patient is taking, including prescriptions from the pharmacy, and any non-prescription medication such as vitamins or herbal preparations. The review is conducted by a pharmacist, in the patient’s home, and can only be conducted following a referral from a general practitioner.

Click here for more information.

Quality Prescribing Initiative

The Practice Incentive Program (PIP) Quality Prescribing Incentive (QPI) aims to encourage practices to keep up to date with information on the quality use of medicines. The PIP QPI rewards participation by practices in a range of activities recognised or provided by the National Prescribing Service (NPS).

The Drug and Therapeutics Information Service (DATIS) provides the NPS educational visiting service to GPs in South Australia. The purpose is to provide independent, evidence based information in therapeutic areas to improve patient outcomes. These NPS educational visits qualify as Quality Prescribing Initiative activities within the Practice Incentives Program.

Click here for more information.